Newstral
Jenny Strasburg
- MBP underlying replacement cost profit of $4.8 billion falls short of forecasts.1 min readmarketwatch.com
- MShell adjusted profit of $9.8 billion beats forecasts, boosted by soaring energy prices 1 min readmarketwatch.com
- Catching Cold in the Countryside: Decadeslong U.K. Studies Inspire New Covid-19 Trialswsj.com
- Startup Behind AstraZeneca Covid-19 Vaccine Plans to File Publicly for U.S. IPO Within Dayswsj.com
- MAstraZeneca: US COVID vaccine trial 79% effectivemarketwatch.com
- MStartup behind AstraZeneca vaccine raises millionsmarketwatch.com
- Fauci Discusses What’s Next in the Covid-19 Crisiswsj.com
- MAstraZeneca COVID vaccine merits outweigh risk: EUmarketwatch.com
- MAstraZeneca vaccine suspended in much of Europemarketwatch.com
- MGermany halts use of AstraZeneca COVID-19 vaccinemarketwatch.com
- MIPO for Oxford COVID-19 vaccine startup in perilmarketwatch.com
- MAstraZeneca: Jabs for new variants need 6 monthsmarketwatch.com
- MAstraZeneca defends dosing error in COVID-19 trialmarketwatch.com
- Today’s Logistics Report: Building Vaccine Supply Chains; Delivery’s Uphill Climb; Farming Looks Upwsj.com
- Oxford, AstraZeneca Vaccine’s Strong Response in Elderly Confirmed in Reviewwsj.com
- U.S. Daily Cases Top 100,000 for First Timewsj.com
- AstraZeneca Expects Covid-19 Vaccine Trial Results This Yearwsj.com
- Fake Accounts Posing as News Organizations Prematurely Declare Election Victorieswsj.com
- Ransomware Attacks Morph Into a Deadly Concernwsj.com
- Deutsche Bank Considers Up to 20,000 Job Cutswsj.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.